News

Ozempic, Wegovy, and Mounjaro. If you've been following weight-loss stocks, you know those are the drugs that have been driving a lot of the bullishness behind Eli Lilly and Novo Nordisk this year

The S&P 500 has rebounded strongly from last year's pullback, but the broad-market index stalled out in August as concerns about rising interest rates and a recovery that may have gotten ahead of

Costco Wholesale (NASDAQ: COST) is one of the most solid retailers in existence. Its product selection and low prices have helped it build a huge following, and renewal rates on its memberships have

Are you looking for some investments that have lots of potential upside in the years ahead? Three stocks that have been struggling this year and could make for underrated buys are Teladoc Health

Since the dawn of streaming video roughly 15 years ago, the media landscape has undergone a paradigm shift. Viewers are no longer saddled with "appointment" television and movies, having embraced

Walt Disney (NYSE: DIS) is the world's largest entertainment operator. It has 12 theme parks, several billion-dollar franchises, and an unmatched content library. However, it's been struggling

Up 41% so far this year on hot sales of its drug Ozempic, Novo Nordisk (NYSE: NVO) isn't wasting any time in teeing up a few attempts at minting its next blockbuster. Ozempic 2.0 is already in the

Cathie Wood's Ark Invest has made a name for itself with bold bets on high-growth stocks. Wood ignores short-term volatility in her exchange-traded funds (ETFs) and invests in companies based on

The S&P 500 has gained 17% year to date after a constellation of factors has lifted investor sentiment, including better-than-expected earnings and stronger-than-expected economic growth. The index

One business story that gets pulled out with painful regularity is the buggy whip, which was a big business until automobiles destroyed the industry. It's a classic tale of disruption, which every

For any investment, getting it to $1 million can be a lofty goal to set. It's by no means an easy task, and will require a sizable buy-in, lots of patience, and good returns along the way. Below

In its brief time on the public markets, Kenvue (NYSE: KVUE) has already shown it has all the makings of a high-quality dividend stock.

Just a short time after its official separation from

Cannabis stocks rallied last week after the U.S. Department of Health and Human Services (HHS) confirmed that it recommended that the Drug Enforcement Administration (DEA) lower the federal

So far, 2023 has represented a resurgence of quality growth stocks that were bludgeoned by last year's bear market. Software giant Adobe (NASDAQ: ADBE) is a prime example. The stock has shot up

Data is the lifeblood of modern businesses, and the ability to process and analyze it in real time can give companies a competitive edge in the digital economy. But traditional data platforms are

Shares of C3.ai (NYSE: AI) dropped 7.8% in after-hours trading on Wednesday, after the enterprise artificial intelligence (AI) application software company released its results for the first quarter

The bulls and bears continue to press their arguments about the viability of copper miner Freeport-McMoRan's (NYSE: FCX) stock. It's a nuanced debate that speaks to many of the broader investing

Enbridge (NYSE: ENB) has an unceasing record of paying dividends. The Canadian energy infrastructure behemoth has paid its shareholders dividends for over 68 years and has increased its payment in

Advanced Micro Devices (NASDAQ: AMD) investors are sitting on solid gains of almost 70% in 2023 thanks mainly to the broader surge in semiconductor stocks, even as the company's financial

Inflation is problematic for all businesses. They have to deal with rising costs, and they're not all able to pass rising prices along to customers without negatively affecting demand. For

Shares of Roku (NASDAQ: ROKU) jumped on Wednesday, rising several percentage points even as the overall market declined. The stock's big move was fueled by news that the company was doubling down on

Investors who bought Meta Platforms (NASDAQ: META) in the beginning of the year are laughing all the way to the bank. As of this writing, the stock has risen 136% year to date. Two consecutive

Growth investing can significantly enrich shareholders over the long haul. The key is to pick well-run businesses in the relatively early innings of their growth cycles.

Having parlayed a $5,000

Pot stocks are jumping again. Hopes are up that a major marijuana-related reform could be coming in the United States after a government agency suggested that the Drug Enforcement Agency (DEA)